Position in ZVRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,720,800
-$657,999 QoQ
Shares Held
120,000
-53.0% QoQ
Ownership
0.202%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#52
of 158 holders
Holding Since
Jun 2021
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZVRA Over Time
Shares Held
Position Value (USD)
Derivatives in ZVRA
reported options exposure · as of Jun 30, 2026CallValue
$1,434,000
CallShares
100,000
PutValue
$28,720,152
PutShares
2,002,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Caption Management, LLC holds $249,760,911 across 78 Biotechnology names. ZVRA ranks #31 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGON |
CG Oncology, Inc.
|
484,461 | $34,420,954 | |
| 2 | INSM |
INSMED Inc
|
236,000 | $25,162,320 | |
| 3 | ERAS |
Erasca, Inc.
|
1,041,225 | $19,075,242 | |
| 4 | CELC |
Celcuity Inc.
|
170,000 | $17,785,400 | |
| 5 | DSGN |
Design Therapeutics, Inc.
|
1,118,098 | $16,178,878 | |
| 6 | MLYS |
Mineralys Therapeutics, Inc.
|
413,087 | $11,145,087 | |
| 7 | REPL |
Replimune Group, Inc.
|
783,873 | $8,677,474 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
120,700 | $7,596,858 |
All Filings in ZVRA
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,434,000 | 100,000 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $1,720,800 | 120,000 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $28,720,152 | 2,002,800 | Put | Sole | 2026-08-14 | |
| 2026-03-31 | $18,666,096 | 2,002,800 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $886,332 | 95,100 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $2,378,799 | 255,236 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,755,584 | 1,200,400 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $9,866,752 | 1,101,200 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $4,839,403 | 540,112 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $9,510,951 | 1,000,100 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $10,925,088 | 1,148,800 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $4,850,965 | 510,091 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $881,000 | 100,000 | Put | Sole | 2025-08-14 | |
| 2025-06-30 | $440,500 | 50,000 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $749,000 | 100,000 | Put | Sole | 2025-05-15 | |
| 2025-03-31 | $127,307 | 16,997 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $430,280 | 62,000 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $1,677,398 | 241,700 | Call | Sole | 2024-11-14 | |
| 2022-09-30 | $62,400 | 10,000 | Shares | Sole | 2022-11-14 | |
| 2022-09-30 | $312,000 | 50,000 | Put | Sole | 2022-11-14 | |
| 2022-06-30 | $223,000 | 50,000 | Call | Sole | 2022-08-15 | |
| 2022-03-31 | $37,725 | 7,500 | Shares | Sole | 2022-05-13 | |
| 2022-03-31 | $213,775 | 42,500 | Put | Sole | 2022-05-13 | |
| 2022-03-31 | $213,775 | 42,500 | Call | Sole | 2022-05-13 | |
| 2021-12-31 | $175,410 | 20,139 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $593,388 | 63,600 | Call | Sole | 2021-11-12 | |
| 2021-06-30 | $815,352 | 63,600 | Call | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||